Publication | Closed Access

Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice

InflammationAtopic DermatitisImmunologySkin AllergyExperimental PruritusDermatologyExperimental DermatologyMedicineCutaneous Barrier DisruptionsHypersensitivity